According to a market report published by Lucintel, the future of the prefilled syringe market looks promising with opportunities in the hospitals, clinics and ambulatory surgical center. The prefilled syringe market is expected to grow with a CAGR of 10% from 2019 to 2024. The major growth drivers for this market are high prevalence of chronic diseases, rising adoption of self-injection devices, need of prolonged drug administration in accurate dosage, and its ease of use specially for elderly patients.
To download report brochure, please go to https://www.lucintel.com/prefilled-syringe-market.aspx and click "report brochure" tab from the menu.
A prefilled syringe is a syringe filled with a fixed quantity of a therapeutic drug. These are novel devices used for delivering drugs. In this market, glass and plastics are used to manufacture prefilled syringe. Glass is the largest segment. This is characterized by minimal risk of infections with the use of glass-based drug delivery syringes.
Within the prefilled syringe market, anaphylaxis, rheumatoid arthritis, and diabetes are the major applications. Diabetes is expected to witness the largest application as it requires constant medication for treatment. Prefilled syringes are ready-to-administer and deliver optimum quantity drug in patient’s body.
Europe will remain the largest market over the forecast period due to growing prevalence of chronic diseases.
Gerresheimer, Schott, Becton, Dickinson and Company, West Pharmaceutical Services, Vetter Pharma International, Weigao Group, OMPI, Catalent, Nipro Corporation, and Med Pro are among the major manufacturers in the prefilled syringe market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the prefilled syringe market by material, product type, design, application, end user, and region. Lucintel has prepared a comprehensive research report titled "Prefilled Syringe market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the prefilled syringe market by material, product type, design, application, end user, and region as follows:
By Material [$M shipment analysis for 2013 – 2024]:
Glass based
Plastic based
By Product Type [$M shipment analysis for 2013 – 2024]:
Conventional Prefilled Syringes
Safety Prefilled Syringes
By Design [$M shipment analysis for 2013 – 2024]:.
Single-chamber
Dual-chamber
Customized
By Application [$M shipment analysis for 2013 – 2024]:
Anaphylaxis
Rheumatoid Arthritis
Diabetes
Others (Vaccines and Other Biotech Drugs)
By End-User [$M shipment analysis for 2013 – 2024]:
Hospitals/Clinics
Ambulatory Surgical Center
Others
By Region [$M shipment analysis for 2013 – 2024]:
North America
United States
Canada
Mexico
Europe
Asia Pacific
Rest of the World
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/prefilled-syringe-market.aspx or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.